Ram K Kallur is an accomplished inventor based in Fountainville, PA (US). He has made significant contributions to the field of pharmaceutical compositions, particularly focusing on nucleotide analogues. His work has led to advancements that enhance the stability and effectiveness of these compounds.

Latest Patents

Ram K Kallur holds a patent for "Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs." This patent discloses compositions that exhibit outstanding storage stability and exceptional resistance to degradation in aqueous solutions. The compositions include orally active nucleotide analogs or prodrugs, such as adefovir dipivoxil and tenofovir disoproxil. Notably, when stored under specific conditions, these compositions maintain a low level of less orally bioavailable impurities, ensuring their efficacy.

Career Highlights

Kallur is currently associated with Sigmapharm Laboratories, LLC, where he continues to innovate in the pharmaceutical sector. His work is pivotal in developing treatments for various diseases, including viral infections and cancer. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Ram K Kallur collaborates with Ishari Piya, contributing to the advancement of their projects and enhancing the overall research output at Sigmapharm Laboratories.

Conclusion

Ram K Kallur's contributions to the field of pharmaceutical compositions demonstrate his commitment to innovation and excellence. His patent on stable nucleotide analogues is a testament to his expertise and the impact of his work on medical treatments.

Profile summary based on public USPTO records.